marcus evans north america conferences

9th Pharmacovigilance, Drug Safety & Risk Management

Maximizing Safety & Mitigating Risk through Successful Prediction, Automation, Real World Data, and Sustained Regulatory Compliance

26-27 Feb 2020
Philadelphia, PA, United States of America


Why You Should Attend

9th Pharmacovigilance, Drug Safety & Risk Management

This 9th installment of the Pharmacovigilance, Drug Safety & Risk Management conference will allow attendees to engage in discussions and experience lessons learned on the most effective solutions for conducting and improving drug safety.

With the constantly changing Pharmaceutical industry, ensuring companies have strong Pharmacovigilance procedures and processes are important to company and product success. The Biopharmaceutical industry has consistent pressure to ensure drug safety through the updates in the PV arena. Companies are looking to enhance their practices for proactive drug safety, leveraging artificial intelligence, and capitalizing on other Pharmacovigilance trends.

 

Key Topics

  • Address signal detection through Risk-Based methodologies by incorporating data and software
  • Optimize Pharmacovigilance (PV) practices by identifying effective use of automation throughout the product lifecycle
  • Enhance proactive and predictive drug safety throughout clinical research to mitigate risks early on
  • Leverage Artificial Intelligence (AI) and Machine Learning (ML) to support overall drug safety and risk management
  • Create Innovative Procedures for Collecting Patient Data from Real-World Channels
  • Previous Attendees Include

    AbbVie
    Accenture
    Astellas
    AstraZeneca
    Bristol-Myers Squibb
    Celgene
    CSL Behring
    Eli Lilly and Company
    Frontier BPM
    Glaukos Corporation
    ICON Clinical Research Inc
    Jazz Pharmaceuticals
    Johnson & Johnson
    Kyowa Kirin
    Macrogenics
    Merck
    Novartis Corporation
    Otsuka Pharmaceuticals
    Pfizer
    Pharmacyclics LLC an Abbvie Company
    Progenics
    Sanofi Pasteur
    Takeda Pharmaceuticals
    Zogenix


    Why Choose marcus evans?

    marcus evans specialises in the research and development of strategic events for senior business executives. From our international network of 63 offices, marcus evans produces over 1000 event days a year on strategic issues in corporate finance, telecommunications, technology, health, transportation, capital markets, human resources and business improvement.

    Above all, marcus evans provides clients with business information and knowledge which enables them to sustain a valuable competitive advantage and makes a positive contribution to their success.




    Event Partners


    Practical Insights From

    Curtis Chang
    Senior Medical Director Pharmacovigilance
    Takeda Pharmaceutical

    William O'Brien
    Director, Medical Safety Assessment, Cardiovascular, Fibrosis and Severe Sepsis
    Bristol-Myers Squibb

    Kenneth Lipetz
    Global Patient Safety Medical Business Advisor/GPS Medical Process Owner
    Eli Lilly and Company

    Khaudeja Bano
    Senior Medical Director
    Abbott

    Linda Lum
    Director, Global Pharmacovigilance and Epidemiology
    Bristol-Myers Squibb

    Theresa Markey
    Director, Global Drug Safety-Pharmacovigilance & Systems
    Mallinckrodt Inc.

    Rosalina Domin
    QA and Deviation Management Head, Senior Director, Global Pharmacovigilance Quality-MCCQ
    Sanofi

    Richard Wolf
    Head of Global Clinical Safety and Pharmacovigilance (GCSP) Regions & Pv Operations
    CSL Behring

    Click Here For Full Agenda

    Voice of Our Customers
    • “I find the 2 day event to be packed full of information to proactively assist current regulatory & strategic challenges in Pharmacovigilance.” –Sanofi
    • “Very informative & interesting while stayed focused in PV/Risk Management. I’m very impressed with the knowledge of the speakers”. – Allergan
    • “I really enjoyed and took lots of information back with me. Had ongoing changes discussed and future topics which made two days very interesting.” – EMD Serono
    • “Great forum for drug safety/PV, epidemiology and regulatory colleagues to collaborate and learn in a very focused forum.” - Gilead Sciences
    Join the Discussion

    Follow on LinkedIn





    Event Contact

    For all enquiries regarding speaking, sponsoring and attending this conference contact:

    Melini Hadjitheori


    455 N Cityfront Plaza 9th Floor,
    Chicago, 60611, USA


    Telephone:
    +1 312 540 6347
    Fax: +1 312 276 8505
    Email: MeliniH@marcusevansch.com